Results 11 to 20 of about 651,453 (295)

Variables associated with pulmonary hypertension screened by echocardiography in chronic myeloid leukemia patients on dasatinib therapy

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundPulmonary hypertension (PH) is a rare but life-threatening adverse event (AE) of dasatinib, but the associated variables are not clear. This study aimed to explore the variables associated with PH by echocardiography in patients with chronic ...
Wenying Jin   +5 more
doaj   +1 more source

Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study

open access: yesFrontiers in Pharmacology, 2022
Introduction: Polypharmacy are commonly observed among older adults with cardiovascular disease. However, multiple medications lead to increased risk of drug-drug interactions (DDIs).
Mei Zhao   +7 more
doaj   +1 more source

High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction. [PDF]

open access: yes, 2020
Background: The introduction of more sensitive cardiac troponin assays has led to increased recognition of myocardial injury in acute illnesses other than acute coronary syndrome.
Adamson, PD   +22 more
core   +4 more sources

Downregulated Circulating Long Non-coding RNA GAS6-AS1 Screens and Predicts Acute Myocardial Infarction

open access: yesAnatolian Journal of Cardiology, 2023
Background: Acute myocardial infarction seriously threatens human health and life quality, which needs novel biomarkers to improve its early detection and development prediction. This study aimed to assess the potential of long non-coding RNA GAS6-AS1 in
Zhenhua Wang, Mingqing Zhang, Yan Fu
doaj   +1 more source

The association between vesicle-associated membrane protein - 8 A/G gene polymorphism and the risk of acute myocardial infarction

open access: yesRevista Colombiana de Cardiología, 2021
Introduction: Until now, only few studies have reported the correlation between vesicle-associated membrane protein-8 (VAMP-8) A/G gene polymorphism and acute myocardial infarction.
Mohammad S. Rohman   +5 more
doaj   +1 more source

Decision making processes in people with symptoms of acute myocardial infarction: qualitative study [PDF]

open access: yes, 2002
Objective To identify, the themes that influence decision making processes used by patients with symptoms of acute myocardial infarction. Design Qualitative study using semistructured interviews.
Lewin, R J P   +3 more
core   +2 more sources

Current ICD10 codes are insufficient to clearly distinguish acute myocardial infarction type: a descriptive study [PDF]

open access: yes, 2013
BackgroundAcute myocardial infarction (AMI) type is an important distinction to be made in both clinical and health care research context, as it determines the treatment of the patient as well as affecting outcomes.
Alex Bottle   +3 more
core   +2 more sources

Type 2 myocardial infarction: the chimaera of cardiology? [PDF]

open access: yes, 2015
The term type 2 myocardial infarction first appeared as part of the universal definition of myocardial infarction. It was introduced to cover a group of patients who had elevation of cardiac troponin but did not meet the traditional criteria for acute ...
[No authors listed]   +46 more
core   +1 more source

Which diagnostic tests are most useful in a chest pain unit protocol? [PDF]

open access: yes, 2005
Background The chest pain unit (CPU) provides rapid diagnostic assessment for patients with acute, undifferentiated chest pain, using a combination of electrocardiographic (ECG) recording, biochemical markers and provocative cardiac testing.
Angelini, K.   +4 more
core   +3 more sources

Traditional and novel diagnostic biomarkers for acute myocardial infarction

open access: yesThe Egyptian Journal of Internal Medicine, 2022
Background Acute myocardial infarction (AMI) is a leading cause of death worldwide. The first hours of acute myocardial infarction are correlated with the highest risk of death.
Husam Khalil
doaj   +1 more source

Home - About - Disclaimer - Privacy